Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company, has announced that its leadership will present at the 44th Annual J.P. Morgan Healthcare Conference. The conference, one of the most anticipated events in the biopharmaceutical industry, brings together investors, analysts, and industry leaders to discuss advances in science, clinical progress, and corporate strategy. Insmed’s participation…